Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Furuse

Showing results (61-70 of 348) with videos related to

Pageof 35
Sort By:
Hepato-Gastroenterology|July 9, 2004
Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stentingHiroshi Ishii, Junji Furuse, Michitaka Nagase, et al.
Oncology|May 13, 2004
Chemotherapy in the treatment of advanced gallbladder cancerHiroshi Ishii, Junji Furuse, Naohiro Yonemoto, et al.
Japanese Journal of Clinical Oncology|July 19, 2005
A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinomaMasafumi Ikeda, Takuji Okusaka, Hideki Ueno, et al.
Japanese Journal of Clinical Oncology|December 12, 2019
A review of changes to and clinical implications of the eighth TNM classification of hepatobiliary and pancreatic cancersMakoto Ueno, Chigusa Morizane, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology|June 13, 2018
New developments in systemic therapy for advanced biliary tract cancerChigusa Morizane, Makoto Ueno, Masafumi Ikeda, et al.
Surgical Case Reports|February 13, 2017
A pathological complete response after combined chemotherapy of gemcitabine and S-1 in advanced biliary tract cancer with para-aortic lymph nodes metastasis: a case reportTakeshi Watanabe, Junji Furuse, Naohiro Okano, et al.
Japanese Journal of Clinical Oncology|May 26, 2017
Postmarketing surveillance study of erlotinib plus gemcitabine for pancreatic cancer in Japan: POLARIS final analysisJunji Furuse, Akihiko Gemma, Wataru Ichikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2007
[Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report]Junji Furuse, Kohei Nakachi, Eiichiro Suzuki, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 13, 2012
Effect of biliary drainage on chemotherapy in patients with biliary tract cancer: an exploratory analysis of the BT22 studyAkira Fukutomi, Junji Furuse, Takuji Okusaka, et al.
Investigational New Drugs|March 22, 2020
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumorsNaohiro Okano, Daisuke Naruge, Kirio Kawai, et al.
Pageof 35

Showing results (61-70 of 348) with videos related to

Sort By:
Pageof 35
Hepato-Gastroenterology|July 9, 2004
Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stentingHiroshi Ishii, Junji Furuse, Michitaka Nagase, et al.
Oncology|May 13, 2004
Chemotherapy in the treatment of advanced gallbladder cancerHiroshi Ishii, Junji Furuse, Naohiro Yonemoto, et al.
Japanese Journal of Clinical Oncology|July 19, 2005
A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinomaMasafumi Ikeda, Takuji Okusaka, Hideki Ueno, et al.
Japanese Journal of Clinical Oncology|December 12, 2019
A review of changes to and clinical implications of the eighth TNM classification of hepatobiliary and pancreatic cancersMakoto Ueno, Chigusa Morizane, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology|June 13, 2018
New developments in systemic therapy for advanced biliary tract cancerChigusa Morizane, Makoto Ueno, Masafumi Ikeda, et al.
Surgical Case Reports|February 13, 2017
A pathological complete response after combined chemotherapy of gemcitabine and S-1 in advanced biliary tract cancer with para-aortic lymph nodes metastasis: a case reportTakeshi Watanabe, Junji Furuse, Naohiro Okano, et al.
Japanese Journal of Clinical Oncology|May 26, 2017
Postmarketing surveillance study of erlotinib plus gemcitabine for pancreatic cancer in Japan: POLARIS final analysisJunji Furuse, Akihiko Gemma, Wataru Ichikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2007
[Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report]Junji Furuse, Kohei Nakachi, Eiichiro Suzuki, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 13, 2012
Effect of biliary drainage on chemotherapy in patients with biliary tract cancer: an exploratory analysis of the BT22 studyAkira Fukutomi, Junji Furuse, Takuji Okusaka, et al.
Investigational New Drugs|March 22, 2020
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumorsNaohiro Okano, Daisuke Naruge, Kirio Kawai, et al.
Pageof 35